Prof. Nordestgaard has studied and worked in Copenhagen, New York, and London. He has for more than 30 years continued his interest in the pathogenesis, diagnosis and treatment of familial hypercholesterolemia, hyperlipidemia, atherosclerosis and cardiovascular disease, and has written extensively on these conditions. He is chairing the Copenhagen General Population Study and is also a steering committee member of the Copenhagen City Heart Study and of several randomised intervention trials. Prof. Børge G. Nordestgaard has supervised 54 Ph.D. students and 26 postdoctoral fellows, and has published 660 original articles and 101 reviews, book chapters, consensus statements, & editorials. His H-index is 109 and he has published 78 highly cited papers. Original articles include publications in New England J Med, Lancet, Nature, Science, Nature Genetics, JAMA, British Medical Journal, PLos Medicine, Eur Heart J, Circulation and JACC.


Remnant cholesterol: Cardiovascular disease risk, guidelines, and treatmentRemnant cholesterol, 2022 EAS Anitschkow LectureWebinar: Beyond targeting LDL cholesterol the role of remnants in cardiovascular diseaseWebinars on-demandEAS Advanced Course in Rare Lipid Disorders - from CopenhagenWebinars on-demandEAS Advanced Course – Rare Lipid Disorders - from LisbonWebinars on-demandIME Session - Should public health recommendations target Lp(a) measurements? - Discussion and Q&AIME Session - Should public health recommendations target Lp(a) measurements?90th EAS Congress 2022Lp(a) a causal risk factor for cardiovascular diseaseIME Session - Should public health recommendations target Lp(a) measurements?90th EAS Congress 2022The 2022 Anitschkow Lecture90th EAS Congress 2022Opening Ceremony incl. Anitschkow LectureThe case for triglyceride-rich lipoproteins and cardiovascular diseaseEAS AC on Epidemiology & GeneticsHow to treat diabetic dyslipidaemia - Introduction85th EAS Congress 2017